ZA200703157B - 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection - Google Patents
3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infectionInfo
- Publication number
- ZA200703157B ZA200703157B ZA200703157A ZA200703157A ZA200703157B ZA 200703157 B ZA200703157 B ZA 200703157B ZA 200703157 A ZA200703157 A ZA 200703157A ZA 200703157 A ZA200703157 A ZA 200703157A ZA 200703157 B ZA200703157 B ZA 200703157B
- Authority
- ZA
- South Africa
- Prior art keywords
- hepatitis
- infection
- prevention
- ether
- treatment
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical class CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title 1
- 208000005176 Hepatitis C Diseases 0.000 title 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 title 1
- 208000010710 hepatitis C virus infection Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61515204P | 2004-10-01 | 2004-10-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200703157B true ZA200703157B (en) | 2008-08-27 |
Family
ID=38880910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200703157A ZA200703157B (en) | 2004-10-01 | 2005-09-30 | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101068829B (en) |
| ZA (1) | ZA200703157B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2280989B1 (en) * | 2008-06-06 | 2016-02-10 | Scynexis, Inc. | Cyclosporin analogs and their use in the treatment of hcv infections |
| WO2012009715A2 (en) * | 2010-07-16 | 2012-01-19 | S&T Global Inc. | Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
| CN103153330B (en) | 2010-08-12 | 2017-08-18 | 美国科技环球有限公司 | Application of the new cyclosporin derivative in the treatment and prevention of virus infection |
| CA2819608C (en) * | 2010-12-03 | 2020-03-31 | S&T Global Inc. | Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
| US9890198B2 (en) | 2010-12-03 | 2018-02-13 | S&T Global Inc. | Cyclosporin derivatives and uses thereof |
| WO2013028615A2 (en) * | 2011-08-19 | 2013-02-28 | S&T Golbal Inc. | Novel cyclosporin derivatives for the treatment and prevention of viral infections |
| WO2014063147A1 (en) * | 2012-10-19 | 2014-04-24 | Scynexis, Inc. | New antiviral macrocycles |
| SG11201601274QA (en) * | 2013-08-26 | 2016-03-30 | Enanta Pharm Inc | Cyclosporin analogues for preventing or treating hepatitis c |
| WO2020037530A1 (en) * | 2018-08-22 | 2020-02-27 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Crystalline form of compound and uses thereof in medicine |
| WO2020118715A1 (en) * | 2018-12-14 | 2020-06-18 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Salts of scy-635 and uses thereof in medicine |
| AU2020363688A1 (en) | 2019-10-12 | 2022-04-21 | Farsight Medical Technology (Shanghai) Co., Ltd. | Treatment and prevention of nephrotoxin-induced kidney injuries |
| CN115335389A (en) * | 2020-03-26 | 2022-11-11 | 睿诺医疗科技（上海）有限公司 | Cyclophilin inhibitors and uses thereof |
| CN114245744A (en) | 2020-04-15 | 2022-03-25 | 睿诺医疗科技（上海）有限公司 | Prevention and treatment of organ damage |
-
2005
- 2005-09-30 CN CN2005800412034A patent/CN101068829B/en not_active Expired - Fee Related
- 2005-09-30 ZA ZA200703157A patent/ZA200703157B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101068829B (en) | 2012-05-30 |
| CN101068829A (en) | 2007-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL190478A0 (en) | Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection | |
| IL207575A0 (en) | Vaccine for prevention and treatment of hiv infection | |
| ZA200709727B (en) | Compounds and methods for the treatment of prevention of flavivirus infections | |
| EP1730167A4 (en) | ACTIVE MACROCYCLIC PEPTIDES AGAINST HEPATITIS C VIRUS | |
| EP1594512A4 (en) | Compounds for the treatment of viral infection | |
| EP1673385A4 (en) | ACTIVE MACROCYCLIC PEPTIDES AGAINST HEPATITIS C VIRUS | |
| IL183537A0 (en) | Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders | |
| IL173909A0 (en) | Use of modified cyclosporins for the treatment of hcv disorders | |
| PL376409A1 (en) | Composition for the treatment of infection by flaviviridae viruses | |
| PL376454A1 (en) | 1-acyl-pyrrolidine derivatives for the treatment of viral infections | |
| TWI347184B (en) | Methods of treating hiv infection | |
| ZA200703157B (en) | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection | |
| IL182087A0 (en) | Type i interferon blocking agents for prevention and treatment of psoriasis | |
| IL189270A0 (en) | Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections | |
| EP1765330A4 (en) | Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease | |
| GB0415181D0 (en) | Compounds for use in the treatment of infection | |
| GB2441094B (en) | Methods for treatment and prevention of infection | |
| EP1812797A4 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
| GB0300078D0 (en) | Composition for the treatment of HIV and AIDS | |
| AU2003299493A8 (en) | Compositions and methods for the treatment of hepatitis c virus infection | |
| AU2003304316A8 (en) | Compounds and methods for the treatment and prevention of bacterial infection | |
| SI1569929T1 (en) | Compounds and methods for the treatment or prevention of flavivirus infections | |
| KR100531651B1 (en) | Pharmaceutical Composition for the Treatment and Prevention of Hepatitis Containing African Situation Mushroom Extract | |
| GB0510257D0 (en) | Methods for treatment and prevention of infection | |
| GB201010682D0 (en) | Methods for treatment and prevention of infection |